Powered by

-Corbus Pharmaceuticals to Host Expert Symposium on the Therapeutic Potential of Targeting the Endocannabinoid System

Dec 10, 2019 - ENP Newswire

Norwood - Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ('Corbus' or the 'Company'), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it will host a symposium on the endocannabinoid system ('ECS') and the therapeutic potential of targeting the ECS.

The symposium will be webcasted live (details below) on Friday, December 13, 2019 from 1:00 PM - 2:30 PM ET.

Yuval Cohen, Ph.D., Chief ...